Artal Group S.A. - CLEMENTIA PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Artal Group S.A. ownership history of CLEMENTIA PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2018$9,996,000
+29.5%
850,000
+22.8%
0.37%
+84.1%
Q3 2018$7,716,000
+193.2%
692,000
+246.0%
0.20%
+258.9%
Q2 2018$2,632,000
-13.1%
200,0000.0%0.06%
+47.4%
Q1 2018$3,030,000200,0000.04%
Other shareholders
CLEMENTIA PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Orbimed Advisors 10,425,225$176,082,0001.68%
NEA Management Company, LLC 2,141,697$36,173,0001.27%
RA Capital Management 585,403$9,887,0000.89%
DAFNA Capital Management LLC 60,000$1,013,0000.63%
DRIEHAUS CAPITAL MANAGEMENT LLC 819,508$13,841,0000.54%
EcoR1 Capital, LLC 194,166$3,279,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 163,000$2,753,0000.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 462,387$7,810,0000.35%
Rock Springs Capital Management LP 345,000$5,827,0000.27%
Perceptive Advisors 704,500$12,582,0000.24%
View complete list of CLEMENTIA PHARMACEUTICALS IN shareholders